fda semaglutide compounding warning november 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded GLP-1 Drugs and Telehealth Providers FDA Shares Safety Data About

The two processes that most commonly predispose to bacterial overgrowth are diminished stomach acid secretion and lack of small intestine motility (31)

Comparing the Two When it comes to results, GLP-1s tend to deliver more significant weight loss

We prioritize third-party testing and no unnecessary synthetic fillers

Histamine-rich foods: Foods like aged cheeses, fermented products, and cured meats can exacerbate histamine intolerance due to their high histamine content

Metformin commonly causes mild gastrointestinal upset initially, while GLP-1 medications may cause nausea, particularly during dose escalationthough nausea typically decreases after 2-3 weeks as the body adjusts

But this is only the beginning, with Ozempic and Wegovy both losing patent protection in China in 2026, in Europe and Japan in 2031, and in the US in 2032